Learn about the gut-brain connection in mental health and how targeting serotonin in the gut could revolutionise ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Johnson & Johnson JNJ announced that the FDA has approved its supplemental new drug application (sNDA), seeking approval for ...

Purpose: The association of antipsychotic and antidepressant drugs with Q-T ... hepatic insufficiency, and stimulant drug abuse contribute to the risk for developing these arrhythmias, as do ...